Incidence of Gonorrhea and Chlamydia Following Human Immunodeficiency Virus Preexposure Prophylaxis Among Men Who Have Sex With Men: A Modeling Study | Zendy

Samuel M. Jenness | Zendy; Kevin M. Weiss | Zendy; Steven M. Goodreau | Zendy; Thomas L. Gift | Zendy; Harrell W. Chesson | Zendy; Karen W. Hoover | Zendy; Dawn K. Smith | Zendy; Albert Liu | Zendy; Patrick S. Sullivan | Zendy; Eli S. Rosenberg | Zendy

Open Access

Incidence of Gonorrhea and Chlamydia Following Human Immunodeficiency Virus Preexposure Prophylaxis Among Men Who Have Sex With Men: A Modeling Study

Author(s) -

Samuel M. Jenness,

Kevin M. Weiss,

Steven M. Goodreau,

Thomas L. Gift,

Harrell W. Chesson,

Karen W. Hoover,

Dawn K. Smith,

Albert Liu,

Patrick S. Sullivan,

Eli S. Rosenberg

Publication year - 2017

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cix439

Subject(s) - medicine , pre exposure prophylaxis , men who have sex with men , gonorrhea , chlamydia , incidence (geometry) , condom , chlamydia trachomatis , gynecology , syphilis , human immunodeficiency virus (hiv) , immunology , physics , optics

Preexposure prophylaxis (PrEP) is highly effective for preventing human immunodeficiency virus (HIV) infection, but risk compensation (RC) in men who have sex with men (MSM) raises concerns about increased sexually transmitted infections (STIs). The Center for Disease Control and Prevention's (CDC's) PrEP guidelines recommend biannual STI screening, which may reduce incidence by treating STIs that would otherwise remain undiagnosed. We investigated these two counteracting phenomena.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research